Human medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 48, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 2 October 2026 - 13:19

Human medicines European public assessment report (EPAR): Sprycel, dasatinib (anhydrous), Date of authorisation: 20/11/2006, Revision: 48, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/sprycel

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters